Cargando…

Full Response of a Localized Renal Tumour after Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation

Graft versus tumor effect has been described in solid metastatic tumor. We reported here the case of a patient treated for an acute myeloid leukemia with reduced-intensity conditioned allograft and the effect of this procedure on concomitant of renal localised cancer. The effect of immune-mediated c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gac, Anne-Claire, Chantepie, Sylvain, Leporrier, Michel, Reman, Oumedaly
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2009
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777241/ https://www.ncbi.nlm.nih.gov/pubmed/19920866 http://dx.doi.org/10.1155/2009/879765

Ejemplares similares

Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial
por: Chantepie, Sylvain P., et al.
Publicado: (2015)

Lymphomatoid Granulomatosis Treated Successfully with Rituximab in a Renal Transplant Patient
por: Castrale, Cindy, et al.
Publicado: (2011)

Reduced-intensity conditioning hematopoietic stem cell transplantation: looking forward to an international consensus
por: Chaudhry, Monazza, et al.
Publicado: (2015)

Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
por: Lee, Seung-Shin, et al.
Publicado: (2020)

Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome
por: Irie, Masahiro, et al.
Publicado: (2022)

Reduced Intensity Allogeneic Hematopoietic Cell Transplantation using Fludarabine-Melphalan conditioning for Treatment of Mature T-cell Lymphomas
por: Delioukina, Maria, et al.
Publicado: (2011)

Review of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in solid tumors excluding breast cancer
por: Karadurmus, Nuri, et al.
Publicado: (2016)

Allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia in ETO positive with reduced-intensity conditioning
por: Guo, Zhi, et al.
Publicado: (2017)

Haploidentical hematopoietic stem cell transplantation using reduced‐intensity conditioning for pediatric patients with familial hemophagocytic lymphohistiocytosis
por: Jia, Chenguang, et al.
Publicado: (2019)

Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosis
por: Gagelmann, Nico, et al.
Publicado: (2022)

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results
por: Koreth, John, et al.
Publicado: (2018)

Correction: Allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia in ETO positive with reduced-intensity conditioning
por: Guo, Zhi, et al.
Publicado: (2019)

Reduced Intensity Conditioning, Combined Transplantation of Haploidentical Hematopoietic Stem Cells and Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia
por: Li, Xiao-Hong, et al.
Publicado: (2014)

Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report
por: Annaloro, Claudio, et al.
Publicado: (2015)

Protective Effect of HLA-DPB1 Mismatch Remains Valid in Reduced-Intensity Conditioning Unrelated Donor Hematopoietic Cell Transplantation
por: Malki, Monzr M. Al, et al.
Publicado: (2019)

An Experience of Donor Lymphocyte Infusion after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
por: Rostami, Tahereh, et al.
Publicado: (2020)

Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend “when and for whom” in 2021?
por: Gagelmann, Nico, et al.
Publicado: (2021)

Association between conditioning intensity and height growth after allogeneic hematopoietic stem cell transplantation in children
por: Uemura, Suguru, et al.
Publicado: (2023)

Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia
por: Pautas, Cécile, et al.
Publicado: (2021)

Correction: Reduced Intensity Conditioning, Combined Transplantation of Haploidentical Hematopoietic Stem Cells and Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia
Publicado: (2015)

Usefulness of Low-Dose Splenic Irradiation prior to Reduced-Intensity Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Elderly Patients with Myelofibrosis
por: Matsubara, Etsuko, et al.
Publicado: (2016)

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia; Current Evidence, and Improving Outcomes Going Forward
por: Leonard, Jessica T., et al.
Publicado: (2018)

Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency
por: Lum, S. H., et al.
Publicado: (2019)

Renal Transplantation with Kidneys Affected by Tumours
por: Khurram, Muhammad Arslan, et al.
Publicado: (2011)

Antibody Response to 2-Dose Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients
por: Maillard, Alexis, et al.
Publicado: (2021)

Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
por: Seydoux, Claire, et al.
Publicado: (2023)

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
por: Çiftçiler, Rafiye, et al.
Publicado: (2019)

Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Dimitrova, Dimana, et al.
Publicado: (2022)

Hematopoietic Stem Cell Transplantation
por: Maedler-Kron, Chelsea, et al.
Publicado: (2016)

Impact of conditioning regimen on peripheral blood hematopoietic cell transplant
por: Burns, Michael, et al.
Publicado: (2019)

Antibody based conditioning for allogeneic hematopoietic stem cell transplantation
por: Saha, Asim, et al.
Publicado: (2022)

Is Hematopoietic Stem Cell Transplantation Required to Unleash the Full Potential of Immunotherapy in Acute Myeloid Leukemia?
por: Abadir, Edward, et al.
Publicado: (2020)

Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect?
por: Xu, Yujun, et al.
Publicado: (2022)

Favorable outcomes with durable chimerism after hematopoietic cell transplantation using busulfan and fludarabine-based reduced-intensity conditioning for pediatric patients with hemophagocytic lymphohistiocytosis
por: Suh, Jin Kyung, et al.
Publicado: (2022)

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Morsink, Linde M., et al.
Publicado: (2020)

Sequential, Autologous Hematopoietic Stem Cell Transplant Followed by Renal Transplant in Multiple Myeloma
por: Bhowmik, D., et al.
Publicado: (2017)

A new intensive conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia
por: Wang, Jingbo, et al.
Publicado: (2018)

Combining Mobilizing Agents with Busulfan to Reduce Chemotherapy-Based Conditioning for Hematopoietic Stem Cell Transplantation
por: Garcia-Perez, Laura, et al.
Publicado: (2021)

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies
por: Law, Arjun Datt, et al.
Publicado: (2018)

Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups
por: Robin, Marie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_74hkq9c1gl5qgvkkn2a8bovqhu